Osteoarthritis treatment using autologous conditioned serum after placebo: Patient considerations and clinical response in a non-randomized case series

BACKGROUND AND PURPOSE: Autologous conditioned serum (ACS) is a disease-modifying drug for treatment of knee osteoarthritis, and modest superiority over placebo was reported in an earlier randomized controlled trial (RCT). We hypothesized that when given the opportunity, placebo-treated patients fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutgers, Marijn, Creemers, Laura B, Yang, Kiem Gie Auw, Raijmakers, Natasja J H, Dhert, Wouter J A, Saris, Daniel B F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2015
Materias:
Miscellaneous
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366668/
https://www.ncbi.nlm.nih.gov/pubmed/25140983
http://dx.doi.org/10.3109/17453674.2014.950467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366668/
https://www.ncbi.nlm.nih.gov/pubmed/25140983
http://dx.doi.org/10.3109/17453674.2014.950467

Ejemplares similares